Dongchao Xu

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

Endoplasmic Reticulum Stress

Anti Inflammatory

Top Venues

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Dongchao Xu, Mengyao Tian, Wangyang Chen, Ying Bian, Xiaofeng Xia, Qiang Liu, Liyun Zheng, Xiaofeng Zhang, Hongzhang Shen
Linderalactone Suppresses Pancreatic Cancer Development In Vitro and In Vivo via Negatively Regulating PI3K/AKT Signaling Pathway. Journal of oncology 2022 (2022)